RSS | Login | Register

Alzheimer’s Disease And Dementias

Carbidopa with levodopa does more than minimize nausea

July 22, 2010

The combination allows increased amounts of levodopa to be available for entry into the central nervous system.

The costs of treating Alzheimer's disease

July 22, 2010

Any delay in nursing-home placement is well worth the investment in medication.

Alzheimer's management  from diagnosis to late stage

Freddi Segal-Gidan, PA, PhD July 01, 2010

Caring for a patient with Alzheimer's disease involves more than assessment and treatment. Education and legal issues must also be considered.

Attacking Alzheimer's through diet

June 01, 2010

Limiting high-fat dairy products, red meat, organ meat, and butter may cut a person's risk of Alzheimer's disease.

New drug options for dementia and Parkinson's disease

Deborah Downey, CNRN, CNS, ANP May 01, 2010

A thorough understanding of the therapies available to patients with dementia or Parkinson's disease is essential to improving outcomes.

Sleepiness may point to Alzheimer's risk

March 01, 2010

Cognitive fluctuations significantly affect dementia severity and neuropsychological performance.

Antipsychotic meds associated with reduced survival in patients with Alzheimer's disease

Alan Ehrlich, MD May 15, 2009

Diabetes, high LDL speed Alzheimer's decline

May 15, 2009

A history of diabetes or high cholesterol (especially LDL) can speed cognitive decline in patients with Alzheimer's disease.

Of what value are folate levels?

May 14, 2009

Ginkgo biloba does not prevent dementia

January 20, 2009

Findings from a large, long-term study dispel the notion that ginkgo biloba—a popular herbal supplement widely purported to improve memory and cognition—prevents dementia or Alzheimer's disease.

Mediterranean diet lowers risk of death

November 10, 2008

Adherence to the eating pattern known as the Mediterranean diet significantly reduces mortality as well as the rates of various illnesses.

MCI more prevalent than thought

November 10, 2008

Prevalence of mild cognitive impairment (MCI) was considerably higher than expected by a team of researchers studying a population-based sample of elderly men and women.